Gonyautoxin: new treatment for healing acute and chronic anal fissures
- PMID: 15812585
- DOI: 10.1007/s10350-004-0893-4
Gonyautoxin: new treatment for healing acute and chronic anal fissures
Abstract
Purpose: The mayor symptoms of chronic anal fissure are permanent pain, intense pain during defecation that lasts for hours, blood in the stools, and sphincter cramps. It is subsequent to formation of fibrosis infiltrate that leads to an increased anal tone with poor healing tendency. This vicious circle leads to fissure recurrence and chronicity. This study was designed to show the efficacy of gonyautoxin infiltration in healing patients with anal fissures.
Methods: Gonyautoxin is a paralyzing phytotoxin produced by dinoflagellates. Fifty recruited patients received clinical examination, including proctoscopy and questionnaire to evaluate the symptoms. Anorectal manometries were performed before and after toxin injection. Doses of 100 units of gonyautoxin in a volume of 1 ml were infiltrated into both sides of the anal fissure in the internal anal sphincter.
Results: Total remission of acute and chronic anal fissures were achieved within 15 and 28 days respectively. Ninety-eight percent of the patients healed before 28 days with a mean time healing of 17.6 +/- 9 days. Only one relapsed during 14 months of follow-up. Neither fecal incontinence nor other side effects were observed. All patients showed immediate sphincter relaxation. The maximum anal resting pressures recorded after two minutes decreased to 56.2 +/- 12.5 percent of baseline.
Conclusions: Gonyautoxin breaks the vicious circle of pain and spasm that leads to anal fissure. This study proposes gonyautoxin anal sphincter infiltration as safe and effective alternative therapeutic approach to conservative, surgical, and botulinum toxin therapies for anal fissures.
Similar articles
-
Treatment of chronic anal fissure by gonyautoxin.Colorectal Dis. 2007 Sep;9(7):619-24. doi: 10.1111/j.1463-1318.2006.01183.x. Colorectal Dis. 2007. PMID: 17824979 Clinical Trial.
-
A comparison of botulinum toxin and saline for the treatment of chronic anal fissure.N Engl J Med. 1998 Jan 22;338(4):217-20. doi: 10.1056/NEJM199801223380402. N Engl J Med. 1998. PMID: 9435326 Clinical Trial.
-
Prospective manometric assessment of botulinum toxin and its correlation with healing of chronic anal fissure.Dis Colon Rectum. 2005 Jul;48(7):1424-31. doi: 10.1007/s10350-005-0025-9. Dis Colon Rectum. 2005. PMID: 15906131
-
Concepts in pathogenesis and treatment of chronic anal fissure--a review of the literature.Am J Gastroenterol. 2003 May;98(5):968-74. doi: 10.1111/j.1572-0241.2003.07423.x. Am J Gastroenterol. 2003. PMID: 12809816 Review.
-
Fissure-in-ano, to divide or not to divide?Acta Chir Belg. 1999 Oct;99(5):215-20. Acta Chir Belg. 1999. PMID: 10582070 Review.
Cited by
-
Identification of promoter elements in the Dolichospermum circinale AWQC131C saxitoxin gene cluster and the experimental analysis of their use for heterologous expression.BMC Microbiol. 2020 Feb 17;20(1):35. doi: 10.1186/s12866-020-1720-3. BMC Microbiol. 2020. PMID: 32070286 Free PMC article.
-
Industrial Applications of Dinoflagellate Phycotoxins Based on Their Modes of Action: A Review.Toxins (Basel). 2020 Dec 18;12(12):805. doi: 10.3390/toxins12120805. Toxins (Basel). 2020. PMID: 33353166 Free PMC article. Review.
-
Recent biotechnological applications of value-added bioactive compounds from microalgae and seaweeds.Bot Stud. 2024 Sep 23;65(1):28. doi: 10.1186/s40529-024-00434-y. Bot Stud. 2024. PMID: 39312045 Free PMC article. Review.
-
A review of chronic anal fissure management.Tech Coloproctol. 2007 Sep;11(3):209-23. doi: 10.1007/s10151-007-0355-9. Epub 2007 Aug 3. Tech Coloproctol. 2007. PMID: 17676270 Review.
-
Neosaxitoxin Inhibits the Expression of Inflammation Markers of the M1 Phenotype in Macrophages.Mar Drugs. 2020 May 27;18(6):283. doi: 10.3390/md18060283. Mar Drugs. 2020. PMID: 32471037 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical